February 13, 2025 - 14:29

WASHINGTON, D.C. — U.S. Senator Alex Padilla (D-Calif.) took to the Senate floor today to express his strong opposition to the nomination of Robert F. Kennedy Jr. as the head of the Department of Health and Human Services (HHS). Padilla highlighted significant concerns regarding the potential public health consequences should Kennedy be confirmed for the position.
In his remarks, Padilla emphasized the importance of appointing a leader at HHS who prioritizes science-based public health policies. He criticized Kennedy for his controversial views and actions, which he argued could undermine trust in health institutions at a time when the nation is still grappling with the aftermath of the COVID-19 pandemic. The senator's comments reflect a growing unease among some lawmakers about the implications of Kennedy's nomination for public health strategy and policy.
Padilla's speech underscores the critical nature of the HHS role, particularly in addressing ongoing health challenges and ensuring the safety and well-being of the American public.
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...